The effects of the king oyster mushroom Pleurotus eryngii (higher Basidiomycetes) on glycemic control in alloxan-induced diabetic mice

International Journal of Medicinal Mushrooms

Volumn 16, Issue 3, 2014, Pages 219-225

  Li, Jian Ping ^a   Lei, Ya Li ^a   Zhan, Huan ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b NATIONAL KEY LABORATORY FOR REMANUFACTURING   (China)

Author keywords

Alloxan; Diabetes mellitus; Glycemic metabolism; Medicinal mushrooms; Pleurotus eryngii

Indexed keywords

FREE RADICAL; FUNGAL EXTRACT; GLIBENCLAMIDE; GLUCOSE; GLYCOGEN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; PLEUROTUS ERYNGII EXTRACT; UNCLASSIFIED DRUG; ALLOXAN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; LIPID; PLANT EXTRACT;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CELL DEATH; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE METABOLISM; GLYCEMIC CONTROL; GLYCOGEN LIVER LEVEL; HYPERGLYCEMIA; INSULIN RELEASE; MEDICINAL MUSHROOM; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; ANIMAL; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIVER; MALE; METABOLISM; PLEUROTUS; VEGETABLE;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLYCOGEN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; LIPIDS; LIVER; MALE; MICE; PLANT EXTRACTS; PLEUROTUS; VEGETABLES;

EID: 84901945303     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v16.i3.20     Document Type: Article

References (18)

1. Lo H-Ch, Wasser SP. Medicinal mushrooms for glycemic control in diabetes mellitus: history, current status, future perspectives, and unsolved problems (review). Int J Med Mushrooms. 2011;13(5):401-26.
2. Nozaki H, Itonori S, Sugita M, Nakamura K, Ohba K, Suzuki A, Kushi Y. Mushroom acidic glycosphingolipid induction of cytokine secretion from murine T cells and proliferation of NK1.1 alpha/beta TCR-double positive cells in vitro. Biochem Biophys Res Commun. 2008;373:435-39.
3. Kalyoncu F, Oskay M, Saǧlam H, Erdoǧan TF, Tamer AU. Antimicrobial and antioxidant activities of mycelia of 10 wild mushroom species. J Med Food. 2010;13:415-19.
4. Mori K, Kobayashi C, Tomita T, Inatomi S, Ikeda M. Antiatherosclerotic effect of the edible mushrooms Pleurotus eryngii (Eringi), Grifola frondosa (Maitake), and Hypsizygus marmoreus (Bunashimeji) in apolipoprotein E-deficient mice. Nutr Res. 2008;28(5):335-42.
5. Guo J, Li C, Wang J, Liu Y, Zhang J. Vanadium-enriched Cordyceps sinensis, a contemporary treatment approach to both diabetes and depression in rats. Evid Based Complement Alternat Med. 2011;2011:450-56.
6. Xu Q, Guo J. Activity and toxicity of Cr (III)-enriched Grifola frondosa in insulin-resistant mice. Biol Trace Elem Res. 2009;131:271-77.
7. Zhou G, Han C. The co-effect of vanadium and fermented mushroom of Coprinus comatus on glycaemic metabolism. Biol Trace Elem Res. 2008;124:20-27.
8. Laight DW, Gunnarsson PT, Kaw AV, Anggård EE, Carrier MJ. Physiological microassay of plasma total antioxidant status in a model of endothelial dysfunction in the rat following experimental oxidant stress in vivo. Environ Toxicol Pharmacol. 1999;7:27-31.
9. Zhang C, Qi X, Shi Y, Sun Y, Li S, Gao X, Yu H. Optimization of cultivation conditions of fermented shaggy ink cap culinary-medicinal mushroom, Coprinus comatus (O.Mull.:Fr.) Pers. (higher Basidiomycetes) rich in Vanadium. Int J Med Mushrooms. 2012;14:189-95.
10. Jayasuriya WJ, Suresh TS, Abeytunga D, Fernando GH, Wanigatunga CA. Oral hypoglycemic activity of culinary-medicinal mushrooms Pleurotus ostreatus and P. cystidiosus (higher Basidiomycetes) in normal and alloxan-induced diabetic Wistar rats. Int J Med Mushrooms. 2012;14:347-55.
11. Guo JY, Han CC, Liu YM. A contemporary treatment approach to both diabetes and depression by Cordyceps sinensis, rich in vanadium. Evid Based Complement Alternat Med. 2010;7(3):387-89.
12. Lei H, Zhang M, Wang Q, Guo S, Han J, Sun H, Wu W. MT-α-glucan from the fruit body of the maitake medicinal mushroom Grifola frondosa (higher Basidiomyetes) shows protective effects for hypoglycemic pancreatic β-cells. Int J Med Mushrooms. 2013;15:373-81.
13. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia. 2000;43:1528-33.
14. Kim BM, Han YM, Shin YJ, Min BH, Park IS. Clusterin expression during regeneration of the pancreatic islet cells in the streptozotocin-induced diabetic rats. Diabetologia. 2001;44(12):2192-202.
15. Sakurai K, Katoh M, Someno K, Fujimoto Y. Apoptosis and mitochondrial damage in INS-1 cells treated with alloxan. Biol Pharmaceut Bull. 2001;24:876-82.
16. Gold AH. The effect of diabetes and insulin on liver glycogen synthetase activation. J Biol Chem. 1970;245:903-5.
17. Manonmani G, Bhavapriya V, Kalpana S, Govindasamy S, Apparanantham T. Antioxidant activity of Cassia fistula (Linn.) flowers in alloxan induced diabetic rats. J Ethnopharmacol. 2005;97:39-42.
18. Zhang XF, Tan BK. Antihyperglycemic and antioxidant properties of Andrographis paniculata in normal and diabetic rats. Clin Exp Pharmacol Physiol. 2000;27:358-63.